Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Piyapoom Pakvisal
Police General Hospital
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
63
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac
Number of pages: 27
Posted: 13 Aug 2022
Passakorn Wanchaijiraboon
,
Panot Sainamthip
,
Nattaya Teeyapun
,
Sutima Luangdilok
,
Yong Poovorawan
,
Nasamon Wanlapakorn
, Piyapoom Pakvisal,
Thiti Susiriwatananont
,
Nicha Zungsontiporn
,
Suebpong Tanasanvimon
,
Virote Sriuranpong
and
Nussara Pakvisal
Phrapokklao Cancer Center of Excellence, Chulalongkorn University - Department of Pharmacology, Chulalongkorn University - Division of Medical Oncology, Chulalongkorn University - Department of Biochemistry, Chulalongkorn University - Center of Excellence in Clinical Virology, Chulalongkorn University - Center of Excellence in Clinical Virology, Police General Hospital, Chulalongkorn University - Division of Medical Oncology, Chulalongkorn University - Division of Medical Oncology, Chulalongkorn University - Division of Medical Oncology, Chulalongkorn University - Division of Medical Oncology and Chulalongkorn University - Division of Medical Oncology
Downloads
63
(933,592)
View PDF
Download
Abstract:
ChAdOx1, CoronaVac, BNT162b2, mRNA-1273, Booster Covid-19 vaccine, Safety, Cancer patients
Feedback
